From the Blackburn lab: Socioeconomic status and cell aging in children.

Posted on August 12, 2012 by Maurice Preter MD

I am studying telomerase-environment interactions. Fascinating, as they say. Not news, but –  poverty and lack of education kills (faster), literally. Link http://biochemistry.ucsf.edu/labs/blackburn/index.php?option=com_content&view=article&id=12&Itemid=8 Here is the abstract: Soc Sci Med. 2012 Jun;74(12):1948-51. Epub 2012 Mar 17. Socioeconomic status and cell … Continue reading →

Posted in Aging, development, epigenetics, Forensic Neuropsychiatry, Health, News | Tagged , , , |

To what extent is mortality predictable from facial photographs?

Posted on August 4, 2012 by Maurice Preter MD

Nifty paper on the predictive validity of the impression of “old age”. Here is the abstract: __________________________________________ Predicting Mortality From Human Faces Dominika Dykiert, PhD, Timothy C. Bates, PhD, Alan J. Gow, PhD, Lars Penke, PhD, John M. Starr, MA, … Continue reading →

Posted in Aging, Health | Tagged , |

Anti-inflammatory utility of Boswellia serrata (frankincense)

Posted on July 27, 2012 by Maurice Preter MD

Reading up on Boswellia serrata – this is a good starter article: http://www.altmedrev.com/publications/13/2/165.pdf “Boswellia serrata Description Boswellia serrata (frankincense) is a moderate-to-large branching tree (growing to a height of 12 feet) found in India, Northern Africa, and the Middle East. … Continue reading →

Posted in Aging, Health, new treatments | Tagged , , , , , |

A role for vitamin D in the treatment of multiple sclerosis (MS)

Posted on July 26, 2012 by Maurice Preter MD

This is such an important topic that I am posting the full-length article. On pubmed at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882221/?tool=pubmed. Neurology. 2010 June 8; 74(23): 1852–1859. doi:  10.1212/WNL.0b013e3181e1cec2 PMCID: PMC2882221 A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis … Continue reading →

Posted in dietary, Health, metabolic, new treatments, Psychiatry/Neurology | Tagged , , , , |

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Posted on July 24, 2012 by Maurice Preter MD

================================================   Nutr Metab (Lond). 2009 Aug 10;6:31. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Source Accera, … Continue reading →

Posted in Aging, dietary, Health, metabolic, News, Psychiatry/Neurology | Tagged , , |